Johnson & Johnson CEO on how close company is to coronavirus vaccine

Johnson & Johnson announced a lead COVID-19 vaccine candidate Monday morning. The company expects to begin phase one human clinical trials by September at the latest. Johnson & Johnson CEO Alex Gorsky joins "Squawk Box" to discuss.